Dynamic Technology Lab Private Ltd Invests $1.21 Million in Privia Health Group, Inc. (NASDAQ:PRVA)

Dynamic Technology Lab Private Ltd bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 66,192 shares of the company’s stock, valued at approximately $1,206,000. Dynamic Technology Lab Private Ltd owned 0.06% of Privia Health Group as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PRVA. Icon Wealth Advisors LLC grew its stake in Privia Health Group by 1,910.1% during the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after buying an additional 285,920 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Privia Health Group by 6.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock valued at $19,380,000 after acquiring an additional 65,152 shares in the last quarter. Intech Investment Management LLC purchased a new stake in Privia Health Group during the 3rd quarter worth $462,000. KBC Group NV increased its holdings in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares in the last quarter. Finally, MQS Management LLC acquired a new stake in Privia Health Group in the 3rd quarter valued at $217,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $21.50 on Wednesday. The stock has a market capitalization of $2.58 billion, a price-to-earnings ratio of 215.02, a PEG ratio of 5.38 and a beta of 0.76. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30. The company’s 50-day simple moving average is $19.03 and its 200-day simple moving average is $18.60.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares in the company, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 14.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Truist Financial boosted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Robert W. Baird upped their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Royal Bank of Canada reiterated an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Finally, KeyCorp began coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $25.07.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.